D. Pertschuk

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model

W. Günzburg, H. Petznek, J. Hlavaty, 2013, Cancer Gene Therapy.

Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids

M. Aghi, N. Kasahara, C. Logg, 2014, Molecular therapy. Methods & clinical development.

Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.

N. Kasahara, F. Hofman, H. Gruber, 2015, Human gene therapy.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

Jeffrey E. Lee, R. Elashoff, D. Morton, 2017, Annals of Surgical Oncology.

Gastroparesis in chronic dyspepsia (CD) and in diabetics with dyspeptic symptoms (DD): Diagnostic sensitivity and specificity of gastric scintigraphy

R. McCallum, G. Tougas, U. Chauhan, 2001 .

AT-02INTRATUMORAL DELIVERY OF THE RETROVIRAL REPLICATING VECTOR (RRV) TOCA 511 IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA: INTERIM REPORT OF PHASE 1 STUDY (NCT 01156584)

Susan M. Chang, T. Cloughesy, L. Liau, 2014 .